CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Senzime AB is developing the CliniSenzTM system, a continuous blood glucose monitoring device that leverages advanced biosensor technology. This innovation aims to improve patient outcomes by providing sensitive and specific glucose tracking, ultimately reducing mortality and enhancing recovery rates.
We are a Swedish medical devices manufacture, Senzime AB, who have been driven by the need to take advantage of an existing core technology to embark on a new strategy to grow based on our vision of becoming the leading provider of analyte evaluation systems, with a turnover of €30.5m by 2020.
To realise this vison we will add a new product line to our portfolio by exploiting an existing biosensor technology that we have developed, as well as the experience and contacts gained on a parallel proj…
SENZIME AB
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
